Profit

FY14 looks solid, though local market has slowed: Glenmark

PUBLISHED ON: May 8, 2013 | Duration: 8 min, 24 sec

  
loading..
Glenn Saldanha, chairman and MD, Glenmark Pharmaceuticals, says that FY14 will bring in solid growth for the company. He talks about the growth US has seen and the margins the company can expect.
ALSO WATCH
Remdesivir, Favipiravir: How Effective Are They Against Covid-19?

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com